Leading producer’s compliance with stringent regulatory requirements drives global expansion Greeley, Colorado, September 21, 2023 – Vantage Hemp Co. (“Vantage” or the “Company”) announces the completion of a rigorous four-day audit conducted by Australia’s Therapeutic Goods Administration (TGA), the country’s...
Vantage Hemp Co. Looks Ahead to 2023 After a Breakout Year in International Markets and New Industries
Industry leader is now setting the bar beyond CBD (cannabidiol) with pharmaceutical-grade production and manufacturing for a variety of plant-based products Vantage Hemp Co. (“Vantage” or the “Company”), has continued to stand out in an ever-changing CBD industry through an...
Pharmaceutical-grade CBD producer shows commitment to increasing white label format capabilities Industry leader, Vantage Hemp Co. (“Vantage” or the “Company”), announces softgel capabilities in response to meeting client and consumer demands. As the Company expands its white label and contract manufacturing services,...
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
Vantage Hemp is a highly accredited CBD extractor - one of North America’s leading hemp processors with both ICH Q7 and WHO GMP certified facilities.
Vantage delivers world leading contract manufacturing, white label, and formulation services to WHO GMP and ICH Q7 standards..
As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.